ADK Diagnos Inc

Diagnos Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE:ADK), a leader in
healthcare technical services including screening, software and algorithm
development, data analysis, and image processing, announced today a further
expansion of the agreement first announced on November 26th 2013, with the first
expansion announced on March 11, 2014, to further increase screening capacity in
the country.


"Having announced a 100% expansion of our screening program in the UAE in
November 2013, we are very pleased to announce an additional 75% expansion
comprised by two contract extensions signed within a period of 8 months of the
original agreement. Our client has seen a material impact on their business in
the UAE and asked us for this increase to capture emerging market demand for
their products and consequently for our services which are helping drive that
demand. As a result of this expansion, the client will now have a total of 14
screening units operating across the UAE and will be able to pursue further
opportunities with key health care providers in the country. We are very happy
that our service is appreciated by the client and it is demonstrating a very
positive impact on their bottom line, as evidenced by subsequent expansions of
the program," said Peter Nowacki, Diagnos' Vice-President.


About DIAGNOS

Founded in 1998, DIAGNOS is a publicly traded Canadian corporation, with a
mission to commercialize technologies to improving decision making processes in
different sectors. DIAGNOS offers products, services, and solutions to clients
in a variety of fields including healthcare and natural resources.


About DIAGNOS Healthcare

DIAGNOS Healthcare is a business division with DIAGNOS Inc., achieving
international recognition as leader in healthcare technical services including,
screening, software and algorithm development, data analysis, and image
processing. Through its Healthcare division, DIAGNOS offers turn-key diabetic
retinopathy screening services to patients in various locations around the
world.


Neither the TSX Venture Exchange nor its Regulation Service Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.


For further information on DIAGNOS, please visit our website at www.diagnos.com
or the SEDAR website at www.sedar.com.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Andre Larente
President
DIAGNOS Inc.
(450) 678-8882 ext 224
www.diagnos.com

Diagnos (TSXV:ADK)
Historical Stock Chart
From Apr 2024 to May 2024

Diagnos (TSXV:ADK)
Historical Stock Chart
From May 2023 to May 2024